Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
06/1995
06/13/1995US5424456 N-arylalkylderivatives of 2-aminomethyl-2,3-dihydro-1,4-benzodioxine and the process of preparation thereof
06/13/1995US5424450 Angiotensin II receptor blocking imidazolinone derivatives
06/13/1995US5424447 Inhibitors of nitric oxide formation from arginine
06/13/1995US5424428 (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]-hydrazono]pr
06/13/1995US5424425 Analgesics, antidepressants, hypotensive agent and treats irritable bowel syndrome and congestive heart failure
06/13/1995US5424326 Treats cardiovascular disorder angina pectoris and erectile dysfunctions
06/13/1995US5424319 Renin inhibitors
06/13/1995US5424314 Anti-anoxic
06/13/1995US5424312 Treating central nervous system disorders, high blood pressure
06/13/1995US5424309 Hypotensive agents
06/13/1995US5424307 Renin inhibitors
06/13/1995US5424303 For treating hypercholesterolemia and hyperlipidemia
06/13/1995US5424294 Modified gangliosides and the functional derivatives thereof
06/11/1995CA2137519A1 4-phenyl-3-substituted 1,4-dihydropyridine esters
06/11/1995CA2137518A1 Dihydropyridines with substituted esters
06/09/1995CA2137446A1 3-(phenylalkylaminoalkyloxy)-5-phenylpyrazole compounds, intermediates for their preparation and pharmaceutical compositions containing them
06/08/1995WO1995015316A1 Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation
06/08/1995WO1995015311A1 Tachykinin antagonists
06/08/1995WO1995015308A1 Crystalline, polymorphic form of (s,s,s)-n-(1-[2-carboxy-3-(n2-mesyllysylamino)propyl]-1-cyclopentylcarbonyl)tyrosine
06/08/1995WO1995015173A1 Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof
06/08/1995WO1995015166A1 Use of aldosterone antagonists to inhibit myocardial fibrosis
06/08/1995WO1995015161A2 Medicament for treating heart insufficiency
06/08/1995DE4421433C1 Transdermal therapeutic system for treatment of, e.g., hypertension
06/08/1995CA2177994A1 Tachykinin antagonists
06/08/1995CA2177978A1 Medicament for treating heart insufficiency
06/08/1995CA2177848A1 Use of aldosterone antagonists to inhibit myocardial fibrosis
06/08/1995CA2177825A1 Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof
06/07/1995EP0656359A1 Substituted 6,11-ethano-6,11-dihydrobenzo[b]quinolizinium salts and compositionsand methods of use thereof
06/07/1995EP0656345A1 Aspartic acid derivatives or homologues thereof and their use in the treatment of neurological diseases
06/07/1995EP0656213A1 Treatment of conditions and disease
06/07/1995EP0656207A1 Non-chlorofluorocarbon aerosol formulations
06/07/1995EP0656206A1 Non-chlorofluorocarbon aerosol formulations
06/07/1995EP0656115A1 Improved detection and therapy of lesions with biotin/avidin conjugates
06/07/1995EP0656029A1 Crosslinked polymeric ammonium salts
06/07/1995EP0656008A1 Thrombin receptor antagonists
06/07/1995EP0656001A1 Novel 2-substituted indane-2-mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase
06/07/1995EP0655996A1 Substituted benzylamino nitrogen containing non-aromatic heterocycles
06/07/1995EP0655923A1 Antiangiogenic oligomers
06/07/1995EP0616532A4 Use of peripheral-type benzodiazepine sites for treatment of cns trauma or disease.
06/07/1995EP0454783B1 Site specific in-vivo activation of therapeutic drugs
06/07/1995CN1103402A Substituted pyrroles
06/07/1995CN1028758C Pyrazolopyrimidinone antianginal agents
06/07/1995CN1028757C Process for preparing heterocyclic derivatives
06/07/1995CN1028755C Azole derivate, manufacturing method and application thereof
06/07/1995CA2137213A1 Imidazopyridines
06/06/1995US5422373 Anti-atherosclerotic aryl compounds
06/06/1995US5422368 With omega chain having a ring as end group, side effect reduction
06/06/1995US5422365 Naphthalene compounds
06/06/1995US5422362 Method to inhibit restenosis
06/06/1995US5422359 α-aminoketone derivatives
06/06/1995US5422349 Renin inhibitors
06/06/1995US5422342 A hydrolase inhibitor comprising a protected oligopeptides for treating fibrose of lungs, liver and skins, atherosclerosis
06/06/1995CA1335816C 4-pyridyl-1,3-dioxan-5-ylalkenoic acid derivatives
06/04/1995CA2137028A1 Pharmaceutical compounds
06/04/1995CA2136904A1 Excitatory amino acid receptor antagonists
06/01/1995WO1995014777A1 p53-BINDING POLYPEPTIDES AND POLYNUCLEOTIDES ENCODING SAME
06/01/1995WO1995014695A1 Novel furanodiazepines
06/01/1995WO1995014694A1 Benzodiazepines
06/01/1995WO1995014683A1 Novel isoxazoline and isoxazole fibrinogen receptor antagonists
06/01/1995WO1995014682A1 Isoxazoline compounds useful as fibrinogen receptor antagonists
06/01/1995WO1995014676A1 3-acylaminobenzodiazepines
06/01/1995WO1995014673A1 4,5-diphenylimidazole derivatives, their preparation and their use as acyl coenzyme a: cholesterol-0-acyl-transferase (acat) inhibitor
06/01/1995WO1995014671A1 3-acylaminobenzazepines
06/01/1995WO1995014670A1 Heterocyclic benzenesulfonylimine derivatives as inhibitors of il-1 action
06/01/1995WO1995014669A1 Novel benzenesulfonylimine derivatives as inhibitors of il-1 action
06/01/1995WO1995014657A1 Alpha-aryl or heteroaryl-substituted amide ester acat inhibitors
06/01/1995WO1995014478A1 Purine compositions and methods for administration
06/01/1995WO1995014473A1 Antiarrhythmic benzodiazepines
06/01/1995WO1995014472A1 Antiarrhythmic benzodiazepines
06/01/1995WO1995014471A1 Antiarrhythmic benzodiazepines
06/01/1995WO1995014470A1 Methods of treating cardiac arrhythmia
06/01/1995WO1995014468A1 Blocking utilization of tetrahydrobiopterin to block induction of nitric oxide synthesis
06/01/1995WO1995014467A1 Therapeutic guanidines
06/01/1995WO1995014464A1 Ssi tyrphostins and pharmaceutical compositions
06/01/1995WO1995014461A1 Therapeutic substituted guanidines
06/01/1995WO1995014384A1 Inhibition of smooth muscle migration and proliferation with hydroxy carbazole compounds
06/01/1995CA2177289A1 Ssi tyrphostins and pharmaceutical compositions
06/01/1995CA2177084A1 Therapeutic guanidines
06/01/1995CA2177081A1 Therapeutic substituted guanidines
06/01/1995CA2177074A1 P53-binding polypeptides and polynucleotides encoding same
06/01/1995CA2176377A1 Inhibition of smooth muscle migration and proliferation with hydroxy carbazole compounds
06/01/1995CA2176251A1 Blocking utilization of tetrahydrobiopterin to block induction of nitric oxide synthesis
06/01/1995CA2176022A1 Antiarrhythmic benzodiazepines
06/01/1995CA2176021A1 Methods of treating cardiac arrhythmia
06/01/1995CA2176020A1 Benzodiazepines
06/01/1995CA2176019A1 3-acylaminobenzazepines
06/01/1995CA2176018A1 Novel furanodiazepines
06/01/1995CA2176016A1 Antiarrhythmic benzodiazepines
06/01/1995CA2176015A1 Antiarrhythmic benzodiazepines
06/01/1995CA2175828A1 Purine compositions and methods for administration
06/01/1995CA2175217A1 3-acylaminobenzodiazepines
06/01/1995CA2174838A1 Novel isoxazoline and isoxazole fibrinogen receptor antagonists
06/01/1995CA2174415A1 Isoxazoline compounds useful as fibrinogen receptor antagonists
06/01/1995CA2154475A1 4,5-diphenylimidazole derivatives, their preparation and their use as acyl coenzyme a: cholesterol-0-acyl-transferase (acat) inhibitor
05/1995
05/31/1995EP0655462A1 Linear adhesion inhibitors
05/31/1995EP0655461A1 Cyclic amino acid derivatives having ACE and NEP inhibiting activity
05/31/1995EP0655460A1 Pharmacotherapeutical use of glutathione derivatives
05/31/1995EP0655442A1 Piperazine derivatives as Tachykinin antagonists
05/31/1995EP0655440A2 1-Aminoethylindoles
05/31/1995EP0655439A2 5,6-Bicyclic glycoprotein IIb IIIa antagonists useful in inhibition of platelet aggregation
1 ... 1427 1428 1429 1430 1431 1432 1433 1434 1435 1436 1437 1438 1439 1440 1441 1442 1443 1444 1445 1446 1447 ... 1595